Ependymoma with C11orf95-MAML2 fusion: presenting with granular cell and ganglion cell features
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Clinical Neurology,Oncology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s10014-020-00388-6.pdf
Reference20 articles.
1. Ostrom QT, Gittleman H, Liao P et al (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol 16(Suppl 4):iv1–iv63
2. Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820
3. Andreiuolo F, Varlet P, Tauziede-Espariat A et al (2019) Childhood supratentorial ependymomas with YAP1-MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features. Brain Pathol 29(2):205–216
4. Pajtler KW, Witt H, Sill M et al (2015) Molecular classification of ependymal tumors across All CNS compartments, histopathological grades, and age groups. Cancer Cell 27(5):728–743
5. Parker M, Mohankumar KM, Punchihewa C et al (2014) C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma. Nature 506(7489):451–455
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. ZFTA-fused supratentorial ependymoma with a novel fusion partner, DUX4;Journal of Neuropathology & Experimental Neurology;2023-06-20
2. Therapeutic potential of pentamidine for glioma‐initiating cells and glioma cells through multimodal antitumor effects;Cancer Science;2023-05-04
3. Updates in the classification of ependymal neoplasms: The 2021 WHO Classification and beyond;Brain Pathology;2022-03-21
4. Ependymoma associated protein Zfta is expressed in immature ependymal cells but is not essential for ependymal development in mice;Scientific Reports;2022-01-27
5. Molecular Classification and Therapeutic Targets in Ependymoma;Cancers;2021-12-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3